Serum advanced glycation end products and glyoxalase-1 levels in Behçet's disease: a cross-sectional study.
OBJECTIVES Behçet's disease (BD) is a chronic, systemic inflammatory disorder. Despite the presence of chronic inflammation in BD, a clear increase in atherosclerotic cardiovascular mortality has not been documented. However, chronic inflammation may contribute to atherogenesis through various pathways, including accel...